Navigation Links
New "second-line" AIDS Drug Shows Promise in Trials

tation in a single amino acid.

The treatment options narrow further if a patient is found to suffer bad side effects from these powerful molecules.

The hope for etravirine is that it will open up a new front against resistant virus and raise the genetic barrier to developing resistance.


'"/>




Page: 1 2

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. New Prostate Cancer Vaccine Shows Promise
3. Ebola Treatment Shows Promise
4. New Drug Shows Significant Improvement In HIV-related Heart Condition
5. Greek Study Shows Living In The Hills May Be Healthier
6. Research Shows Carbon Monoxide Prevents Inflammations
7. Latest Research Shows That Multivitamins Might Not Prevent Infections In All Elderly
8. Novartis MS Drug Shows Promising Results
9. MRI Shows Emotional Changes During Menstrual Cycle
10. Bronchiolo-alveolar Carcinoma Shows Sonographic Pattern Of Pneumonia
11. AIDS drug GS 9137 Shows Promise
Post Your Comments:
(Date:1/9/2009)... Blackbaud, Inc. today announced that it will ...n of Canada that will create a unified national CR...rleston, S.C. (Vocus) January 9, 2009 -- Blackbaud...ll develop a custom solution for The Kidney Founda... CRM and web presence., , , , ,"We selected ...
(Date:1/9/2009)...Thursday, January 8, Rhode Island Hospital treated... known as NanoKnife. Damian Dupuy, MD, director of...national pioneer in ablation treatment, performed ...n a kidney tumor in the United States. , NanoKni...le electroporation (IRE) technology" -- pulses of ...
(Date:1/9/2009)...effects of nitrous oxide laughing gas may be enh...w study by UCL (University College London). The st...nder the gas mean that dental patients may benefi...ation. , Nitrous oxide (laughing gas) is commonl... treatment, but some dentists believe their patien...
(Date:1/9/2009)...ch., Jan. 9 Stryker Corp...ales were $1,718 million for the fourth,quarter o...s of $1,658 million,for the fourth quarter of 200...ember 31, 2008, representing a 12.0% increase over...ecember 31, 2007. On a constant currency basis,...
Breaking Medicine News(10 mins):Health News:Blackbaud to Deliver National CRM Database and Bilingual Website for The Kidney Foundation of Canada 2Health News:Blackbaud to Deliver National CRM Database and Bilingual Website for The Kidney Foundation of Canada 3Health News:Blackbaud to Deliver National CRM Database and Bilingual Website for The Kidney Foundation of Canada 4Health News:Rhode Island Hospital first in US to treat kidney tumor with new device using electrical pulses 2Health News:People are more suggestible under laughing gas 2Health News:People are more suggestible under laughing gas 3Health News:Stryker Updates Expected 2008 Results and Provides 2009 Outlook 2Health News:Stryker Updates Expected 2008 Results and Provides 2009 Outlook 3Health News:Stryker Updates Expected 2008 Results and Provides 2009 Outlook 4
...orsens the quality of life of patients with rheuma...ain, fatigue, physical function and overall utili...searchers led by Dr Siri Lillegraven at Diakonhjem... part of the study, researchers examined 1041 obes...
...ty in patients with rheumatoid arthritis (RA) is s...d significantly from the first trimester to the th...is effect extended into the postpartum stage. Th...tive study to confirm the relationship between RA ...
...f environmental and genetic risk factors in the de... researchers in Sweden have identified smoking, a ...c indicators as important risk factors in the deve...esent a significant step towards better understand...
...d Sciences have won FDA approval for a new drug to... pulmonary arterial hypertension, liver injury, bi...re disease, impotence pill, Viagra, endothelin, re...ls, ambrisentan, Letairis.US-based biotechnology c...
Other Medicine News:Health News:Intensity of Rheumatoid Arthritis Significantly Reduced by Pregnancy 2Health News:Risk Factors for Rheumatoid Arthritis 2Health News:New Hypertension Drug Wins FDA Approval 2
(Date:1/9/2009)...wire/ -- ESBATech AG, a leading developer of antib...tiation of the Phase I/IIa clinical development of...steoarthritis (OA). This double-blind, randomized,...designed to investigate the safety, tolerability a...ia intra-articular administration to patients with...
(Date:1/8/2009)...o, Jan. 8 IntelligentMDx a develope...ays, today announced that verification studies of ... complete. , , Under the verification protocol...d reproducibility and robustness of the BK Viral Q... agreed with internally generated analytical perfo...
(Date:1/7/2009).../ -- ImQuest Life Sciences announced today the suc...od and Drug Administration to initiate human clini...bitor IQP-0410. ImQuest anticipates initiating the...QP-0410 is a novel small molecule inhibitor of HIV...ranscriptase inhibitor (NNRTI). The compound posse...
(Date:1/6/2009)...intaining a healthy immune system , , PURCHASE,... study in Nutrition and Cancer (60(5), 643-651) ...ka, Japan has shown that AHCC (Active Hexose Corre...sing the number of dendritic cells (DCs). DCs are ...esenting foreign substances to other immune system...
Breaking Medicine Technology:ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 2ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 3ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 4Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Interleukin Genetics Inc Reports Third Quarter 2007 Financial Results 1727 1Interleukin Genetics Inc Reports Third Quarter 2007 Financial Results 1727 2Interleukin Genetics Inc Reports Third Quarter 2007 Financial Results 1727 3Interleukin Genetics Inc Reports Third Quarter 2007 Financial Results 1727 4Interleukin Genetics Inc Reports Third Quarter 2007 Financial Results 1727 5Interleukin Genetics Inc Reports Third Quarter 2007 Financial Results 1727 6New Research Identifies Effective Teen Sex Education Programs and Other Interventions 5799 1New Research Identifies Effective Teen Sex Education Programs and Other Interventions 5799 2New Research Identifies Effective Teen Sex Education Programs and Other Interventions 5799 3Webcast Advisory The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results 5794 1CURE International Plans Hospital in Bethlehem 3A 5789 1CURE International Plans Hospital in Bethlehem 3A 5789 2
...data from XL999 studies,scheduled for presentation...CO, May 30, 2007 /PRNewswire-FirstCall/ --,Exelixi...ials of,the company,s investigational compounds XL...an Society of Clinical Oncology Annual,Meeting (AS...llinois. , , -- Data from the Phase I trials of...
...d) considered by many as,first-line in secondary s...07 - New data presented today at the,16th European...,with dipyridamole plus ASA (extended-release dipy...Asasantin® Retard) is superior,to ASA* alone i...ad,a TIA or minor ischaemic stroke, irrespective o...
Other Medicine Technology:Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 3New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 4
...rvical plate system is the lowest profile plate cl...integrated lock mechanism, which is designed to pr...ciate the narrow width, which decreases the amount... also offers easy to use instrumentation and the a...
... been providing excellence in Ambulatory ECG Monit...s in the diagnosis and treatment of potentially li...-of-the-art equipment and technology combined with...service makes LifeWatch the provider of choice. Ou...
The Solo microplate incubator is an extremely compact and portable unit for incubating a single microplate up to 50C. ,Solo HT (high temperature) incubates applications requiring higher temperatures
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -
Medicine Products: